Simulations Plus and Partners Awarded New FDA Grant to Validate In Vitro-In Vivo Extrapolation Methods for Complex Formulations
Simulations Plus, Inc. (SLP)
Last simulations plus, inc. earnings: 4/9 04:35 pm
Check Earnings Report
US:NASDAQ Investor Relations:
simulations-plus.com/software/overview
Company Research
Source: Business Wire
Collaboration goal to develop alternative methods to assess clinical performance of product variants under different conditions LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus”), a leading provider of biosimulation, simulation-enabled performance and intelligence solutions, and medical communications to the biopharma industry, today announced a newly funded grant from the U.S. Food and Drug Administration (FDA), secured in partnership with the University of Strathclyde and InnoGI Technologies. The project is expected to improve the understanding of amorphous solid dispersion (ASD) formulations in different conditions and predict the impact of food and pH-dependent drug-drug interactions (DDIs) through the combination of novel in vitro testing and mechanistic modeling and simulation.For this award, Professor Hannah Batchelor, through her lab at the University of Strathclyde, will analyze ASD drug products and their respective formulation v
Show less
Read more
Impact Snapshot
Event Time:
SLP
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SLP alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SLP alerts
High impacting Simulations Plus, Inc. news events
Weekly update
A roundup of the hottest topics
SLP
News
- Simulations Plus (SLP) Stock Jumps 8.9%: Will It Continue to Soar? [Yahoo! Finance]Yahoo! Finance
- Biosimulation Market to Hit USD 9.18 Billion by 2029 with 16.7% CAGR | MarketsandMarkets™. [Yahoo! Finance]Yahoo! Finance
- Simulations Plus to Participate in the BTIG Digital Health ForumBusiness Wire
- Simulations Plus, Inc. (NASDAQ: SLP) was upgraded by analysts at Stephens to a "strong-buy" rating.MarketBeat
- Simulations Plus, Inc. (NASDAQ: SLP) is now covered by analysts at Stephens. They set an "overweight" rating and a $39.00 price target on the stock.MarketBeat
SLP
Earnings
- 10/23/24 - Beat
SLP
Sec Filings
- 11/5/24 - Form 4
- 11/5/24 - Form 4
- 11/5/24 - Form 4
- SLP's page on the SEC website